Vacuum-assisted mini-percutaneous nephrolithotomy is associated with lower rates of infectious complications compared to vacuum-cleaner procedure in patients at high risk for infections: a single-center experience - Summary - MDSpire
Advertisement
Vacuum-assisted mini-percutaneous nephrolithotomy is associated with lower rates of infectious complications compared to vacuum-cleaner procedure in patients at high risk for infections: a single-center experience
To investigate the impact of vacuum-assisted mini-PCNL (vamPCNL) on the rate of infectious complications compared to standard mini-PCNL in patients with high-risk factors for infections, focusing on specific outcomes such as infection rates and recovery times.
Key Findings:
Vacuum-assisted mini-PCNL significantly reduced the rate of infectious complications compared to standard mini-PCNL, with statistical significance.
Patients with high-risk factors for infections benefited more from the vacuum-assisted technique, indicating a tailored approach to surgical intervention.
The use of vacuum-assisted access sheath decreased operative time and intrarenal pressure, contributing to improved patient outcomes.
Interpretation:
The findings suggest that vamPCNL is a safer alternative for high-risk patients, potentially lowering the incidence of post-operative infections, which could influence surgical practice guidelines.
Limitations:
Single-center study may limit generalizability of results; further multicenter studies are needed to validate findings.
Retrospective design may introduce selection bias, which should be acknowledged when interpreting results.
Conclusion:
Vacuum-assisted mini-PCNL is associated with lower rates of infectious complications in high-risk patients, indicating its potential as a preferred technique in this population, aligning with current trends in minimally invasive surgery.
by Andrea Marmiroli, Marco Nizzardo, Stefano Paolo Zanetti, Gianpaolo Lucignani, Matteo Turetti, Carlo Silvani, Franco Gadda, Fabrizio Longo, Elisa De Lorenzis, Giancarlo Albo, Andrea Salonia, Emanuele Montanari, Luca Boeri
Kidney cancer is a growing global health problem, and both clinicians and policymakers need to prepare for a steep rise in the number of cases,” said Alexander Kutikov, MD, FACS, Chair of the Department of Urology at Fox Chase Cancer Center, and senior author of a landmark international study published in European Urology, which demonstrates that if current trends continue, kidney cancer cases could double by 2050
